EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Global Health Economics and Sustainability

ISSN 2972-4570 · AccScience Publishing

Latest articles

  1. Budgetary impact of new label indications after initial drug registration in Brazil: A case study of pembrolizumab and trastuzumab deruxtecan

    Marcus Carvalho Borin, Mariana Michel Barbosa, Camila Oliveira Pereira, Carina Rejane Martins, Daniel Pitchon dos Reis, Geraldo José Coelho Ribeiro, Júlia Teixeira Tupinambás, Karina de Castro Zocrato, Lélia Maria de Almeida Carvalho, Marcela Pinto de Freitas, Maria da Glória Cruvinel Horta, Mariza Cristina Torres Talim, Ernesto Gomes de Azevedo, Sergio Adriano Loureiro Bersan, Silvana Marcia Bruschi Kelles

    Published: 2023DOI: 10.36922/ghes.0994

  2. Assessing the impact of fast-track drug registration by Anvisa in Brazil: A descriptive study of new drug registrations from 2017 to 2022

    Marcus Carvalho Borin, Mariana Michel Barbosa, Camila Oliveira Pereira, Carina Rejane Martins, Daniel Pitchon dos Reis, Geraldo José Coelho Ribeiro, Júlia Teixeira Tupinambás, Karina de Castro Zocrato, Lélia Maria de Almeida Carvalho, Arcela Pinto de Freitas, Maria da Glória Cruvinel Horta, Mariza Cristina Torres Talim, Ernesto Gomes de Azevedo, Sergio Adriano Loureiro Bersan, Silvana Marcia Bruschi Kelles

    Published: 2023DOI: 10.36922/ghes.0995

Volumes

2026 · 172025 · 452024 · 942023 · 19

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.